Taurine, a common ingredient in energy drinks, has been linked to leukemia cell growth. New research suggests targeting taurine uptake for leukemia treatment strategies.

Taurine was found to “significantly accelerate disease progression” in a new study of the supplement, commonly given to chemotherapy patients